United Health Products Stock Performance
| UEEC Stock | USD 0.06 0.0009 1.48% |
On a scale of 0 to 100, United Health holds a performance score of 4. The entity has a beta of 0.3, which indicates not very significant fluctuations relative to the market. As returns on the market increase, United Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding United Health is expected to be smaller as well. Please check United Health's downside variance, rate of daily change, and the relationship between the maximum drawdown and skewness , to make a quick decision on whether United Health's existing price patterns will revert.
Risk-Adjusted Performance
Soft
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in United Health Products are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, United Health exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
United |
United Health Relative Risk vs. Return Landscape
If you would invest 5.50 in United Health Products on November 16, 2025 and sell it today you would earn a total of 0.69 from holding United Health Products or generate 12.55% return on investment over 90 days. United Health Products is currently generating 0.3691% in daily expected returns and assumes 5.9559% risk (volatility on return distribution) over the 90 days horizon. In different words, 53% of otc stocks are less volatile than United, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
United Health Target Price Odds to finish over Current Price
The tendency of United OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.06 | 90 days | 0.06 | about 19.0 |
Based on a normal probability distribution, the odds of United Health to move above the current price in 90 days from now is about 19.0 (This United Health Products probability density function shows the probability of United OTC Stock to fall within a particular range of prices over 90 days) .
United Health Price Density |
| Price |
Predictive Modules for United Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as United Health Products. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of United Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
United Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. United Health is not an exception. The market had few large corrections towards the United Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold United Health Products, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of United Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.56 | |
β | Beta against Dow Jones | 0.30 | |
σ | Overall volatility | 0 | |
Ir | Information ratio | 0.07 |
United Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of United Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for United Health Products can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| United Health had very high historical volatility over the last 90 days | |
| United Health has some characteristics of a very speculative penny stock | |
| United Health Products currently holds 666.01 K in liabilities with Debt to Equity (D/E) ratio of 0.63, which is about average as compared to similar companies. United Health Products has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist United Health until it has trouble settling it off, either with new capital or with free cash flow. So, United Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like United Health Products sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for United to invest in growth at high rates of return. When we think about United Health's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 59. Net Loss for the year was (30.55 M) with profit before overhead, payroll, taxes, and interest of 34. | |
| United Health Products currently holds about 6.42 K in cash with (828.08 K) of positive cash flow from operations. | |
| Roughly 16.0% of United Health outstanding shares are owned by insiders | |
| Latest headline from seekingalpha.com: Biotricity GAAP EPS of -0.04, revenue of 4M |
United Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of United OTC Stock often depends not only on the future outlook of the current and potential United Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. United Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 225.7 M | |
| Cash And Short Term Investments | 21.8 K |
United Health Fundamentals Growth
United OTC Stock prices reflect investors' perceptions of the future prospects and financial health of United Health, and United Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on United OTC Stock performance.
| Return On Asset | -5.31 | |||
| Operating Margin | (88.52) % | |||
| Current Valuation | 57.8 M | |||
| Shares Outstanding | 229.47 M | |||
| Price To Earning | (52.33) X | |||
| Price To Book | 5,319 X | |||
| Price To Sales | 1,591 X | |||
| Revenue | 59 | |||
| EBITDA | (29.93 M) | |||
| Cash And Equivalents | 6.42 K | |||
| Total Debt | 666.01 K | |||
| Debt To Equity | 0.62 % | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (828.08 K) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 26.8 K | |||
| Retained Earnings | (12.44 M) | |||
| Current Asset | 338 K | |||
| Current Liabilities | 1.18 M | |||
About United Health Performance
By analyzing United Health's fundamental ratios, stakeholders can gain valuable insights into United Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if United Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if United Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
United Health Products, Inc. develops, manufactures, and markets hemostatic gauze products for the healthcare and wound care sectors in the United States. United Health Products, Inc. was incorporated in 1997 and is headquartered in Henderson, Nevada. United Health operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange.Things to note about United Health Products performance evaluation
Checking the ongoing alerts about United Health for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for United Health Products help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| United Health had very high historical volatility over the last 90 days | |
| United Health has some characteristics of a very speculative penny stock | |
| United Health Products currently holds 666.01 K in liabilities with Debt to Equity (D/E) ratio of 0.63, which is about average as compared to similar companies. United Health Products has a current ratio of 0.01, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist United Health until it has trouble settling it off, either with new capital or with free cash flow. So, United Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like United Health Products sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for United to invest in growth at high rates of return. When we think about United Health's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 59. Net Loss for the year was (30.55 M) with profit before overhead, payroll, taxes, and interest of 34. | |
| United Health Products currently holds about 6.42 K in cash with (828.08 K) of positive cash flow from operations. | |
| Roughly 16.0% of United Health outstanding shares are owned by insiders | |
| Latest headline from seekingalpha.com: Biotricity GAAP EPS of -0.04, revenue of 4M |
- Analyzing United Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether United Health's stock is overvalued or undervalued compared to its peers.
- Examining United Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating United Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of United Health's management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of United Health's otc stock. These opinions can provide insight into United Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for United OTC Stock analysis
When running United Health's price analysis, check to measure United Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Health is operating at the current time. Most of United Health's value examination focuses on studying past and present price action to predict the probability of United Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Health's price. Additionally, you may evaluate how the addition of United Health to your portfolios can decrease your overall portfolio volatility.
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |